Weixiang Zhan

Guangdong Provincial Key Laboratory Of Colorectal And Pelvic Floor Diseases
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

VG161 oncolytic virus remodels the tumor microenvironment by expanding CD3+ macrophages and enhancing antitumor immunity.

VG161 oncolytic virus remodels the tumor microenvironment by expanding CD3+ macrophages and enhancing antitumor immunity.

Journal: Cancer letters
Published: March 17, 2026

PTEN deficiency impairs MHC-I-mediated tumour immunity via NRF2-dependent autophagy in microsatellite stable colorectal cancer.

PTEN deficiency impairs MHC-I-mediated tumour immunity via NRF2-dependent autophagy in microsatellite stable colorectal cancer.

Journal: Gut
Published: January 19, 2026

Cathepsin-D-mediated MHC class I degradation contributes to immune evasion in colorectal cancer.

Cathepsin-D-mediated MHC class I degradation contributes to immune evasion in colorectal cancer.

Journal: Cell reports. Medicine
Published: June 23, 2025

TRIM29 promotes liver metastasis via enhancing hepatic colonization by stabilizing FAM83H to regulate keratin network in colorectal cancer.

TRIM29 promotes liver metastasis via enhancing hepatic colonization by stabilizing FAM83H to regulate keratin network in colorectal cancer.

Journal: Cellular signalling
Published: April 01, 2025

PD-1 blockade plus COX inhibitors in dMMR metastatic colorectal cancer: Clinical, genomic, and immunologic analyses from the PCOX trial.

PD-1 blockade plus COX inhibitors in dMMR metastatic colorectal cancer: Clinical, genomic, and immunologic analyses from the PCOX trial.

Journal: Med (New York, N.Y.)
Published: December 15, 2023

Efficacy of additional locoregional therapy based on systemic therapy after intrahepatic progression for BCLC stage B/C hepatocellular carcinoma: A real-world study.

Efficacy of additional locoregional therapy based on systemic therapy after intrahepatic progression for BCLC stage B/C hepatocellular carcinoma: A real-world study.

Journal: International immunopharmacology
Published: October 13, 2023

Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy.

Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy.

Journal: Molecular medicine (Cambridge, Mass.)
Published: July 20, 2023

Tumor stroma Siglec15 expression is a poor prognosis predictor in colon adenocarcinoma.

Tumor stroma Siglec15 expression is a poor prognosis predictor in colon adenocarcinoma.

Journal: Journal of Cancer
Published: June 29, 2023

Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1-BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy.

Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1-BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy.

Journal: Acta pharmaceutica Sinica. B
Published: November 27, 2022

Identification of immune cell infiltration landscape for predicting prognosis of colorectal cancer.

Identification of immune cell infiltration landscape for predicting prognosis of colorectal cancer.

Journal: Gastroenterology report
Published: July 02, 2022

Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity.

Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity.

Journal: Cell research
Published: November 09, 2021

RMI2 plays crucial roles in growth and metastasis of lung cancer.

RMI2 plays crucial roles in growth and metastasis of lung cancer.

Journal: Signal transduction and targeted therapy
Published: May 08, 2020
Showing 1-12 of 14

Last Updated: 09/26/2026